Scientists have uncovered a surprising connection between sugar metabolism and alcohol addiction, identifying a potential new therapeutic target for treating alcohol-associated liver disease (ALD) and alcohol use disorder (AUD).
When doctors detect elevated levels of SerpinB3 in a blood test, it can signal that something is seriously wrong, from hard-to-treat cancers to severe inflammatory conditions.
Reading brain activity with advanced technologies is not a new concept. Generating detailed, structured descriptions of complex visual perceptions or thoughts remains difficult.
KAOHSIUNG CITY, Taiwan, Nov. 7, 2025 /PRNewswire/ — TAICEND is set to officially launch its groundbreaking new product — TAICEND Collagen Dressing — in 2026. Extracted from premium fish skin, the collagen is produced through a patented low-temperature extraction technology combined with a proprietary formulation, resulting in a high-purity fish collagen suitable for advanced wound dressings.
Researchers in Shanghai have reported in a study, recently published in Science Advances, that they’ve successfully decoded Mandarin Chinese language in real time with the help of a brain-computer interface (BCI) framework.
New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.
The saying goes that you should stay out of the kitchen if you can’t take the heat, but new research suggests otherwise—for the sake of your blood pressure.
Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.
DALLAS, Nov. 6, 2025 /PRNewswire/ — Dallas-based MedCAD has been awarded 510(k) FDA clearance for its AccuStride fixation plates, part of a patient-specific solution available to surgeons as a complete foot and ankle (F&A) system. The company received 510(k) FDA clearance for its foot and ankle guides and planning system in March 2025. The AccuStride implant and surgical guide system coupled with the company’s proprietary planning software will enable foot and ankle surgeons to correct multiple related pathologies in a single procedure.
CAESAREA, Israel, Nov. 6, 2025 /PRNewswire/ — Nitinotes Ltd., a medical device company transforming the treatment of obesity, today announced it has received CE Mark approval for the EndoZip™ System, the first fully automated suturing platform for endoscopic sleeve gastroplasty (ESG). The milestone clearance enables Nitinotes to begin commercialization across the European Union and other CE Mark-accepting markets.